The ASC market's revenues, Dr. Farid Namin's PPE manufacturer and more — 4 GI industry notes

Here are four updates from GI practices and companies over the past week:

1. The gastroenterology ASC market had revenues of $7.21 billion in 2019 and has $10.27 billion in its sights for 2027.

2. Exact Sciences provided the Kentucky Department for Public Health a grant for 1,000 Cologuard kits.

3. Gastroenterologist Farid Namin, MD, opened a personal protective equipment manufacturer after overcoming procurement obstacles early in the pandemic.

4. The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test.

More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don't
Stryker's ASC-focused business: 3 things to know

 

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers